menu search

ANIP / ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
BAUDETTE, Minn., Aug. 24, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference in New York City as follows: Read More
Posted: Aug 24 2023, 06:50
Author Name: GlobeNewsWire
Views: 110594

ANIP News  

ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note

By Zacks Investment Research
November 1, 2023

ANI Pharmaceuticals (ANIP) Stock Drops Despite Market Gains: Important Facts to Note

ANI Pharmaceuticals (ANIP) closed at $61.66 in the latest trading session, marking a -0.13% move from the prior day. more_horizontal

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

By GlobeNewsWire
October 25, 2023

ANI Pharmaceuticals to Discuss Third Quarter 2023 Financial Results on November 8, 2023, at 8:30 a.m. ET

BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the more_horizontal

ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know

By Zacks Investment Research
October 20, 2023

ANI Pharmaceuticals (ANIP) Increases Despite Market Slip: Here's What You Need to Know

ANI Pharmaceuticals (ANIP) closed at $57.44 in the latest trading session, marking a +0.23% move from the prior day. more_horizontal

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why

By Zacks Investment Research
October 6, 2023

ANI Pharmaceuticals (ANIP) Stock Sinks As Market Gains: Here's Why

The latest trading day saw ANI Pharmaceuticals (ANIP) settling at $58.39, representing a -0.41% change from its previous close. more_horizontal

Here's Why You Should Add ANI Pharmaceuticals (ANIP) to Your Portfolio

By Zacks Investment Research
September 11, 2023

Here's Why You Should Add ANI Pharmaceuticals (ANIP) to Your Portfolio

ANI Pharmaceuticals (ANIP), a top-ranked stock, has a diverse portfolio of rare disease and generic medicines. Its Purified Cortrophin Gel is witnessi more_horizontal

ANI (ANIP) Is a Great Choice for 'Trend' Investors, Here's Why

By Zacks Investment Research
September 8, 2023

ANI (ANIP) Is a Great Choice for 'Trend' Investors, Here's Why

If you are looking for stocks that are well positioned to maintain their recent uptrend, ANI (ANIP) could be a great choice. It is one of the several more_horizontal

What Makes ANI (ANIP) a New Strong Buy Stock

By Zacks Investment Research
August 25, 2023

What Makes ANI (ANIP) a New Strong Buy Stock

ANI (ANIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). more_horizontal

New Strong Buy Stocks for August 25th

By Zacks Investment Research
August 25, 2023

New Strong Buy Stocks for August 25th

ANIP, NVMI, AZPN, GRNT and CVLG have been added to the Zacks Rank #1 (Strong Buy) List on August 25, 2023. more_horizontal


Search within

Pages Search Results: